Paired Activating and Inhibitory Immunoglobulin-like Receptors, MAIR-I and MAIR-II, Regulate Mast Cell and Macrophage Activation

Katsumi Yotsumoto, Yasushi Okoshi, Kazuko Shibuya, +10

The Journal of Experimental Medicine

Macrophage ActivationMast Cell DisorderNegative SignalsImmunologyImmune Regulation +19

Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor

Chigusa Nakahashi-Oda, Satoko Tahara‐Hanaoka, Masamichi Shoji, +9

The Journal of Experimental Medicine

Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP chemotherapy

Suk‐young Lee, Naoki Kurita, Yasuhisa Yokoyama, +4

Supportive Care in Cancer

Lymphoid NeoplasiaDiabetesImmunologyPathologyGlucocorticoid +2

Successful treatment of a patient with subcutaneous panniculitis‐like T‐cell lymphoma with high‐dose chemotherapy and total body irradiation

Harumi Y. Mukai, Yasushi Okoshi, Seiichi Shimizu, +6

European Journal Of Haematology

<i>In vivo</i> T‐cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA‐mismatched haploidentical transplantation

Yoshinobu Kanda, Kumi Oshima, Shinichi Kako, +13

American Journal of Hematology

Cell TherapyFatal Cmv DiseaseImmunologyImmunotherapyAplastic Anemia +14

Detection of the <i>STAT5B–RARA</i> fusion transcript in acute promyelocytic leukemia with the normal chromosome 17 on G‐banding

Manabu Kusakabe, Kazumi Suzukawa, Toru Nanmoku, +8

European Journal Of Haematology

Dual Assemblies of an Activating Immune Receptor, MAIR-II, with ITAM-Bearing Adapters DAP12 and FcRγ Chain on Peritoneal Macrophages

Chigusa Nakahashi, Satoko Tahara‐Hanaoka, Naoya Totsuka, +6

The Journal of Immunology

Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia

Chikashi Yoshida, Takuya Komeno, Mitsuo Hori, +16

International Journal of Hematology

Hematological MalignancyChronic Myeloid LeukemiaOncologyMixed-phenotype Acute LeukemiaMalignant Blood Disorder +9

Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology &amp; Oncology Clinical Study Group

Kana Sakamoto, Hideki Nakasone, Shigeharu Tsurumi, +12

Journal of Thrombosis and Thrombolysis

Retrospective StudyImmunohematologyThrombosisHematological MalignancyAutoimmune Disease +8

Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension study

Shinya Katsutani, Yoshiaki Tomiyama, Akiro Kimura, +10

International Journal of Hematology

ThrombopoiesisThrombosisVenous ThrombosisAutoimmune DiseaseBlood Platelet +10